Vijaya Diagnostic Centre Limited reported a 20.4% year-on-year increase in revenue from operations to ₹1,880.5 million for the first quarter of FY26. The company's PAT stood at ₹383.4 million, with an EBITDA margin of 39.1%.
Q1 FY26 Financial Results (in ₹ million)
Particulars
Q1 FY26
Q1 FY25
YoY Change
Q4 FY25
QoQ Change
FY25
FY24
YoY Change
Revenue from Operations
1,880.5
1,562.2
20.4%
1,732.4
8.5%
6,813.9
5,478.1
24.4%
Cost of materials consumed
214.1
187.6
14.2%
221.7
-3.4%
847.6
654.4
29.5%
Employee benefits expense
316.1
273.6
15.5%
284.0
11.3%
1,121.5
902.2
24.3%
Other expenses
615.0
488.6
25.9%
538.1
14.3%
2,112.6
1,712.5
23.4%
EBITDA
735.3
612.4
20.1%
688.6
6.8%
2,732.2
2,209.0
23.7%
EBITDA Margin (%)
39.1%
39.2%
-10BPS
39.8%
-65BPS
40.1%
40.3%
-23BPS
Other income
70.5
35.6
97.8%
55.5
27.0%
183.2
208.2
-12.0%
Depreciation and amortization expense
208.9
166.3
25.6%
188.2
11.0%
706.0
570.0
23.9%
EBIT
596.9
481.7
23.9%
555.9
7.4%
2,209.4
1,847.2
19.6%
Finance costs
74.9
62.7
19.5%
71.9
4.1%
267.4
239.9
11.5%
Profit before Exceptional Items & Tax
522.1
419.0
24.6%
484.0
7.9%
1,941.9
1,607.3
20.8%
Profit before Tax
522.1
419.0
24.6%
473.7
10.2%
1,931.6
1,586.8
21.7%
Tax expenses
136.2
104.0
31.0%
125.1
8.9%
493.7
390.4
26.4%
Profit before Minority Interest
385.9
315.1
22.5%
348.6
10.7%
1,437.9
1,196.4
20.2%
Minority Interest
2.5
1.6
56.4%
2.3
10.1%
7.2
8.1
-11.5%
Profit after Tax (PAT)
383.4
313.5
22.3%
346.4
10.7%
1,430.8
1,188.3
20.4%
PAT Margin (%)
20.4%
20.1%
32BPS
20.0%
39BPS
21.0%
21.7%
-69BPS
EPS - Basic (INR)
3.8
3.1
22.9%
3.4
11.3%
13.9
11.6
20.0%
Financial Performance
Vijaya Diagnostic Centre reported a revenue from operations of ₹1,880.5 million for Q1 FY26, marking a 20.4% increase compared to ₹1,562.2 million in Q1 FY25. The company's EBITDA stood at ₹735.3 million, with an EBITDA margin of 39.1%. Profit after Tax (PAT) was reported at ₹383.4 million, with a PAT margin of 20.4%.
Operational Highlights
The company performed 3.94 million tests in Q1 FY26, compared to 3.38 million tests in Q1 FY25. Footfalls increased to 1.10 million from 0.96 million in the same period last year. Revenue per test increased to ₹477 from ₹462, while revenue per footfall decreased to ₹1,707 from ₹1,621.
Management Commentary
Ms. Suprita Reddy, MD & CEO of Vijaya Diagnostic Centre Ltd., commented on the Q1 FY26 results, noting the strong financial quarter with a 20.4% YoY growth. She highlighted the double-digit growth in the Hyderabad market and the operational status of new hubs in Pune, Bengaluru, and West Bengal. The Nizamabad hub centre achieved break-even within two quarters of full-fledged operations. The company plans to commission three hubs in Q2 FY26 across its Core Geography and West Bengal.
Strategic Expansion
Vijaya Diagnostic Centre is strategically expanding in alignment with its vision. The company successfully acquired PH, Pune's largest B2C integrated diagnostic chain. Two hubs in HSR Layout and Yelahanka, Bengaluru, were inaugurated in Q1 FY26. The company is also on track to launch two more hubs in Nandyal and Khammam (AP & Telangana) by Q2 FY26.
Key Developments
All new hubs are now fully operational. The company is on track to commission a state-of-the-art hub in Nandyal (AP) and Khammam (Telangana) in Q2 FY26. Additionally, a hub in Kasba (WB) is also on track to be commissioned in Q2 FY26.
